Absci Investor Presentation Deck
PARTNERSHIPS
Technology validated through
industry-leading collaborations
ā MERCK
"Merck leans into Al with $610M in
biobucks for Absci drug discovery pact"
"At Merck we are continually evaluating new ways to build,
expand, and refine our biologics capabilities. Absci's platform
offers a compelling opportunity to design new biologic
candidates and explore the expression of complex proteins."*
Dr. Fiona Marshall
Former SVP, Head of Discovery,
Preclinical and Translational Medicine
ABSCI CORPORATION 2023 ALL RIGHTS RESERVED
*https://investors.absci.com/news-releases/news-release-details/absci-announces-research-collaboration-merck
NVIDIA
"Absci collaborates with NVIDIA, pioneer in
Al & compute technology to accelerate
vision of creating drugs in silico"
"Absci's powerful data generation and Al protein engineering
platform is already helping the drug discovery industry, and
NVIDIA is excited to help power and scale Absci's in silico
technologies to achieve the best positive impact."
Kimberly Powell
Vice President of Healthcare
absci. 44View entire presentation